 | Up a level |
Verdoia, Monica and Suryapranata, Harry and Damen, Sander and Camaro, Cyril and Benit, Edouard. and Barbieri, Lucia and Rasoul, Saman and Liew, Houng Bang and Polad, Jawed and Wan Ahmad, Wan Azman and Zambahari, Robaayah and Lalmand, Jacques and van der Schaaf, Renè J. and Koh, Tian Hai and Timmermans, Philippe and Dilling-Boer, Dagmara and Veenstra, Leo F. and Van't Hof, Arnoud W. J. and Lee, Stephen Wai Luen and Roolvink, Vincent and Ligtenberg, Erik and Postma, Sonja and Kolkman, Evelien J. J. and Brouwer, Marc A. and Kedhi, Elvin and De Luca, Giuseppe (2021) Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial. Journal of Thrombosis And Thrombolysis, 52 (3). pp. 797-807. ISSN 0929-5305, DOI https://doi.org/10.1007/s11239-021-02439-x.
Kedhi, Elvin and Verdoia, Monica and Suryapranata, Harry and Damen, Sander and Camaro, Cyril and Benit, Edouard and Barbieri, Lucia and Rasoul, Saman and Liew, Houng B. and Polad, Jawed and Ahmad, Wan Azman Wan and Zambahari, Robaayah and Lalmand, Jacques and van der Schaaf, Rene J. and Koh, Tian H. and Timmermans, Philippe and Dilling-Boer, Dagmara and Veenstra, Leo F. and van' t Hof, Arnoud W. J. and Lee, Stephen W. L. and Roolvink, Vincent and Ligtenberg, Erik and Postma, Sonja and Kolkman, Evelien J. J. and Brouwer, Marc A. and Dudek, Dariusz and De Luca, Giuseppe (2021) Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial. Atherosclerosis, 321. pp. 39-44. ISSN 0021-9150, DOI https://doi.org/10.1016/j.atherosclerosis.2021.02.006.
